A Realistic Alecensa (Alectinib) Approval Scenario with Cigna in Pennsylvania (From Request to Yes)
Answer Box: Getting Alecensa (Alectinib) Approved by Cigna in Pennsylvania
Quick Path to Approval: Cigna requires prior authorization for Alecensa (alectinib) in ALK-positive NSCLC. Submit documented ALK-positive test results, pathology confirming NSCLC, and prescriber attestation via Cigna's PA portal. Most approvals occur within 72 hours for metastatic cases;